Behaviorally, the improvement in cognitive function, as evidenced by enhanced performance in the Morris Water Maze test in EVsM1‐CCR5‐treated mice, underscores the potential of targeting microglial‐derived EVs to mitigate cognitive decline. The gene discussed is CCR5; the disease is Mental deterioration.